Hoechst 33342-induced apoptosis is associated with decreased immunoreactive topoisomerase I and topoisomerase I-DNA complex formation

Annals of Clinical and Laboratory Science

Volumn 31, Issue 2, 2001, Pages 187-198

  Zhang, X ^a   Kiechle, F ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Apoptosis; Hoechst 33258; Hoechst 33342; Topoisomerase I; Topoisomerase I DNA complex

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; AUTOANTIBODY; DNA; DNA TOPOISOMERASE; HOE 33342; PHOSPHORUS 32; PLASMID DNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL STRAIN HL 60; CONTROLLED STUDY; COVALENT BOND; DNA PROTEIN COMPLEX; DNA STRAND BREAKAGE; ENZYME ACTIVITY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; SCLERODERMA; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; BENZIMIDAZOLES; BISBENZIMIDE; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; DNA; DNA TOPOISOMERASES, TYPE I; DNA, SUPERHELICAL; HL-60 CELLS; HUMANS; MICE; MUSCLES; PHOSPHORUS RADIOISOTOPES; PLASMIDS; SCLERODERMA, SYSTEMIC;

ANIMALIA; SCLERODERMA;

EID: 0035045836     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. DNA topoisomerases
2. A model for the mechanism of human topoisomerase I
3. Topoisomerase poisons: Harnessing the dark side of enzyme mechanism
4. Eukaryotic DNA topoisomerases I
5. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note
6. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors
7. Cell death induced by topoisomerase-targeted drugs: More questions than answers
8. Apoptosis: A brief review
9. Death receptors: Signaling and modulation
10. Caspases: Enemies within
11. Diverse molecular provocation of programmed cell death
12. Flow cytometric ratio analysis of the Hoechst 33342 emission spectrum: Multiparametric characterization of apoptotic lymphocytes
13. Induction of apoptosis in endothelial cells treated with cholesterol oxide
14. A mammalian cell mutant with enhanced capacity to dissociate a bis-benzimidazole dye-DNA complex
15. Conformation of B-DNA containing O6-ethyl-G-C base pairs stabilized by minor groove binding drugs: Molecular structure of d(CGC[e6G]-AATTCGCG complexed with Hoechst 33258 or Hoechst 33342
16. DNA minor groove-binding ligands: A different class of mammalian DNA topoisomerase I inhibitors
17. How and how much can Hoechst 33258 cause unwinding in a DNA duplex?
18. Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA
19. Effects of analogs of the DNA minor groove binder Hoechst 33258 on topoisomerase II and I mediated activities
20. Mechanism of Hoechst 33342-induced apoptosis in BC3H-1 myocytes
21. Hoechst 33342-induced apoptosis in BC3H-1 myocytes
22. Hoechst 33342 induces apoptosis in hepatoma cells and inhibits topoisomerase I in vivo
23. Hoechst 33342 induces apoptosis in HL-60 cells and inhibits topoisomerase I in vivo
24. Hoechst 33342 induces apoptosis, inhibits topoisomerase I and alters TATA box binding protein/DNA complexes in HT-144 melanoma cells
25. Hoechst 33342 induces apoptosis and alters TATA box binding protein/DNA complexes in nuclei from HL-60 cells
26. Hoechst 33342 induces apoptosis and alters TATA box binding protein/DNA complexes in nuclei from BC3H-1 myocytes
27. Hoechst 33342-induced apoptosis is associated with intracellular accumulation of E2F-1 protein in BC3H-1 myocytes and HL-60 cells
28. Assestment of mitochondrial function in cells grown in tissue culture
29. Differential poisoning of human and Aspergillus nidulans DNA topoisomerase I by bi- and terbenz-imidazoles
30. Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma)
31. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients
32. Camptothecin induction of a time- and concentration-dependent decrease of topoisomerase I and its implication in camptothecin activity
33. Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression system
34. Activation of intracellular proteases is an early event in TNF-induced apoptosis
35. Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: Ligand-induced DNA-protein crossinking and responses to topoisomerase poisons
36. The domain organization of human topoisomerase I
37. Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis
38. Biochemical and biophysical analyses of recombinant forms of human topoisomerase I
39. Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes
40. DNA-dependent protein kinase is one of a subset of auto-antigens specifically cleaved early during apoptosis
41. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis